BAC BV, a Dutch provider of antibody-based affinity purification technology, has announced a strategic collaboration with Life Technologies, a manufacturer of molecular diagnostic and research-use products, which will bring the range of BAC's CaptureSelect affinity ligand specificities to Life Technologies' Poros chromatography media and pre-packed HPLC columns.
BAC BV, a Dutch provider of antibody-based affinity purification technology, has announced a strategic collaboration with Life Technologies, a manufacturer of molecular diagnostic and research-use products, which will bring the range of BAC's CaptureSelect affinity ligand specificities to Life Technologies' POROS chromatography media and pre-packed HPLC columns. According to the company this suite of products will provide a range of specificities and column formats for applications from discovery through to process monitoring.
"We are very excited to be able to provide a continuously evolving range of specificities and column formats that will allow more researchers to access the benefits of CaptureSelect technology", commented Laurens Sierkstra, CEO of BAC. "Scientists will be able to routinely use CaptureSelect ligands in formats that support QbD approaches for process development and monitoring."
The companies report that the collaboration will create a range of ready-to-use HPLC columns pre-packed with CaptureSelect affinity ligands immobilized on POROS chromatography media. Designed for the high pressures and flow-rates necessary to provide the real-time results for biopharmaceutical quality assurance needs, the companies claim that the selectivity of these columns will support Process Analytical Technology for almost any biopharmaceutical manufacturing process.
For more information about the company, visit their website at www.bacbv.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.